EUVIMEDEUVIMED entdecken
Crossref

The rationale for testing drug combinations in aging intervention studies

Kavita Sharma, Juan Wang, Zhou Jiang, Jenna Klug, Martin Darvas, Denise M. Imai, Timothy Snider, Laura Niedernhofer, Warren Ladiges

Aging Pathobiology and Therapeutics · 2019

DOI: 10.31491/apt.2019.12.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Pathobiology and Therapeutics, 2019. Verfasst von Kavita Sharma und 8 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Sharma, K., Wang, J., Jiang, Z., Klug, J., Darvas, M., Imai, D. M., Snider, T., Niedernhofer, L., & Ladiges, W. (2019). The rationale for testing drug combinations in aging intervention studies. Aging Pathobiology and Therapeutics. https://doi.org/10.31491/apt.2019.12.001

Vancouver

Sharma K, Wang J, Jiang Z, Klug J, Darvas M, Imai DM, et al. The rationale for testing drug combinations in aging intervention studies. Aging Pathobiology and Therapeutics. 2019. doi:10.31491/apt.2019.12.001

BibTeX
@article{Sharma2019,
  author = {Sharma, Kavita and Wang, Juan and Jiang, Zhou and Klug, Jenna and Darvas, Martin and Imai, Denise M. and Snider, Timothy and Niedernhofer, Laura and Ladiges, Warren},
  title = {The rationale for testing drug combinations in aging intervention studies},
  journal = {Aging Pathobiology and Therapeutics},
  year = {2019},
  doi = {10.31491/apt.2019.12.001}
}
Kostenlos starten →